UNBLOCKING OR ACTIVATION OF THE CELLULAR IMMUNE MECHANISM BY INDUCED PROTEOLYSIS IN PATIENTS WITH CANCER
- 17 August 1974
- journal article
- Published by Elsevier in The Lancet
- Vol. 304 (7877) , 382-384
- https://doi.org/10.1016/s0140-6736(74)91761-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- B.C.G. PLUS PROTEASE I IN MALIGNANT MELANOMAThe Lancet, 1973
- DNCB — Reactivity and Skin IrritationNew England Journal of Medicine, 1973
- Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating AntigenBritish Journal of Cancer, 1972
- Requiem for the Nature ConservancyNature, 1972
- Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytesInternational Journal of Cancer, 1972
- The effects of protease I of Aspergillus oryzae (brinase) on membrane permeability and growth of landschütz ascites tumour cellsInternational Journal of Cancer, 1971
- Impaired immunologic reactivity and recurrence following cancer surgeryCancer, 1970
- INHIBITION OF ANTIPLASMIN, AND FIBRINOLYTIC EFFECT OF PROTEASE IN PATIENTS WITH CANCERThe Lancet, 1968
- The physiology of fibrinolysisIrish Journal of Medical Science, 1967
- Human Lymphocyte Migration as a Parameter of HypersensitivityActa Medica Scandinavica, 1967